![Christian Roesky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christian Roesky
Amministratore Delegato presso Novaliq GmbH
Profilo
Christian Roesky is currently the Chief Executive Officer & Managing Director at Novaliq GmbH since 2016.
He holds a doctorate degree from Freiberg University of Mining & Technology.
Posizioni attive di Christian Roesky
Società | Posizione | Inizio |
---|---|---|
Novaliq GmbH
![]() Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Amministratore Delegato | 01/11/2016 |
Formazione di Christian Roesky
Freiberg University of Mining & Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Novaliq GmbH
![]() Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Health Technology |
- Borsa valori
- Insiders
- Christian Roesky